Ischemia-modified albumin as an oxidative stress marker in preeclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 3, 2011, Pages 418-421

  Üstün, Yusuf ^a   Engin Üstün, Yaprak ^a   Öztürk, Özlem ^b   Alanbay, Ibrahim ^b   Yaman, Halil ^b  

^a INONU UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

ischaemia modified albumin; Preeclampsia

Indexed keywords

ISCHEMIA MODIFIED ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ISCHEMIA; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; PROTEIN PROCESSING, POST-TRANSLATIONAL; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 79751478215     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.497879     Document Type: Article

References (19)

1. Grimes DA. The morbidity and mortality of pregnancy: still risky business. Am J Obstet Gynecol 1994;170: 1489-1494. (Pubitemid 24185441)
2. Anwaruddin S, Januzzi JL, Baggish AL, Lewandrowski EL, Lewandrowski KB. Ischemia modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 2005;123:140-145. (Pubitemid 40066181)
3. Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J, Mookadam F, Hill SA. Capability of ischemia modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. Can Med Assoc J 2005;172:1685-1690. (Pubitemid 40896860)
4. Christenson RL, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464-470. (Pubitemid 32222460)
5. Wu AB, Morris DL, Fletcher DR, Apple FS, Christenson RH, Painter PC. Analysis of the albumin cobalt binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol 2001;1:147-151.
6. Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Karahan SC, Topbas M, Aydin M, Eraydin I, Akcan B. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 2008;26:874-878.
7. Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, Schetinger MR. Association between ischemiamodified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009;42: 666-671.
8. Guven S, Alver A, Mentese A, Ilhan FC, Calapoglu M, Unsal MA. The novel ischemia marker ischemia-modified albumin is increased in normal pregnancies. Acta Obstet Gynecol Scand 2009;88:479-482.
9. Prefumo F, Gaze DC, Papageorghiou AT, Collinson PO, Thilaganathan B. First trimester maternal serum ischaemiamodified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development. Hum Reprod 2007;22:2029-2032. (Pubitemid 47062775)
10. van Rijn BB, Franx A, Sikkema JM, van Rijn HJ, Bruinse HW, Voorbij HA. Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy 2008;27:159-167. (Pubitemid 351892682)
11. Valle Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, Bodanese LC. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin EndocrinolMetab 2010;95:586-591.
12. Iacovidou N, Briana DD, Boutsikou M, Liosi S, Baka S, Boutsikou T, Hassiakos D, Malamitsi-Puchner A. Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies.Mediators Inflamm 2008;2008: 523081.
13. Bar-Or D, Rael LT, Bar-Or R, Slone DS, Mains CW, Rao NK, Curtis CG. The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta 2008;387: 120-127. (Pubitemid 350050944)
14. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006;27:939-958. (Pubitemid 44204033)
15. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179: 1359-1375. (Pubitemid 28533800)
16. Ustun Y, Engin-Ustun Y, Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005;121:154-158. (Pubitemid 41074086)
17. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-1204. (Pubitemid 20007682)
18. Zeteroglu S, Ustün Y, Ustün YE. Placental and cord malondialdehyde and maternal and perinatal outcomes. Int J Gynaecol Obstet. 2004;85:47-49. (Pubitemid 38438278)
19. Papageorghiou AT, Prefumo F, Leslie K, Gaze DC, Collinson PO, Thilaganathan B. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin. Hum Reprod 2008;23:803-806.